FindTrial
Sign In

K-115 clinical pharmacology study

K-115 clinical pharmacology study

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080223507
Enrollment
30
Registered
2017-04-14
Start date
2017-04-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

POAG, etc

Interventions

investigational material(s) Generic name etc : K-115 INN of investigational material : Therapeutic category code : 131 Agents for ophthalmic use Dosage and Administration for Investigational material

Sponsors

Kowa Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Untreated IOP >= 21mmHg 2.Age:20years old or more 3.Sex:Both

Exclusion criteria

Exclusion criteria: 1.Patients whose visual acuity is below 0.3 2.Patients thought to use glaucoma medication 3.Patients thought to wear contact lenses etc.

Design outcomes

Primary

MeasureTime frame
Efficacy, safety Efficacy:Intraocular pressure Safety:adverse event—

Secondary

MeasureTime frame
Efficacy, safety Efficacy:Intraocular pressure Safety:ophthalmologic examination, etc—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026